Apart from the comparable importance between these antigens and CD138 in this type of cancer, this marker has gained considerable attention in the therapeutic panorama of MM as it shares important functional features with the promising candidates mentioned above, including significant presence and easy accessibility on the malignant cell membrane. This evidence concerns the gene SDC1 and Miyoshi myopathy.